1. Home >
  2. M&A >
  3. Growth Capital >
  4. United States >
  5. Massachusetts >
  6. InTandem Capital Partners Invests In Adams Clinical

Investment Summary

InTandem Capital Partners Invests In Adams Clinical

On May 21, 2024, private equity firm InTandem Capital Partners invested in life science company Adams Clinical

Investment Highlights
  • This is InTandem Capital Partners’ 1st transaction in the Life Science sector.
  • This is InTandem Capital Partners’ 8th transaction in the United States.
  • This is InTandem Capital Partners’ 2nd transaction in Massachusetts.

Investment Summary
Date 2024-05-21
Target Adams Clinical
Sector Life Science
Investor(s) InTandem Capital Partners
Deal Type Growth Capital
Advisor(s) Cantor Fitzgerald (Financial)
Brown Rudnick (Legal)

Target

Adams Clinical

Watertown, Massachusetts, United States
Adams Clinical is a clinical trial site network that provides advancing research for the central nervous system with locations across the Northeast. The Company’s recruitment and retention mechanisms ensure high-quality outcomes for its participants, sponsors, and CROs. Adams Clinical is based in Watertown, Massachusetts.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

InTandem Capital Partners

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2011
Size Small
Type Sector Agnostic
DESCRIPTION

InTandem Capital Partners is a private equity firm focused on opportunities in the healthcare and insurance sectors. The Firm targets scalable businesses with low technology risk and recurring revenues. Prospective companies are generally profitable with $5 to $15 million of EBITDA. InTandem Capital Partners was established in 2011 and is headquartered in New York City.

DEAL STATS #
Overall 8 of 8
Sector: Life Science M&A 1 of 1
Type: Growth Capital M&A Deals 5 of 5
State: Massachusetts M&A 2 of 2
Country: United States M&A 8 of 8
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-08-02 OrthoNebraska

Omaha, Nebraska, United States

OrthoNebraska is a provider of orthopedic and musculoskeletal care. OrthoNebraska’s comprehensive care includes both surgical and non-surgical intervention, supported by a range of sub-specialized providers. OrthoNebraska was founded in 2004 and is based in Omaha, Nebraska.

Buy -
Mergr

Solution for

Product

Company

Legal